Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-2445
Full Text
Open PDFAbstract
Available in full text
Date
March 16, 2012
Authors
Publisher
American Association for Cancer Research (AACR)